No abstract available
MeSH terms
-
Adolescent
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Budesonide / administration & dosage
-
Budesonide / adverse effects*
-
Budesonide / therapeutic use
-
Chromosomes, Human, Pair 7
-
Combined Modality Therapy
-
Crohn Disease / complications
-
Crohn Disease / drug therapy*
-
Cytarabine / administration & dosage
-
Drug Therapy, Combination
-
Etoposide / administration & dosage
-
Female
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Idarubicin / administration & dosage
-
Immunosuppressive Agents / adverse effects*
-
Immunosuppressive Agents / therapeutic use
-
Leukemia, Monocytic, Acute / drug therapy
-
Leukemia, Monocytic, Acute / etiology*
-
Leukemia, Monocytic, Acute / immunology
-
Leukemia, Monocytic, Acute / surgery
-
Male
-
Mercaptopurine / administration & dosage
-
Mercaptopurine / adverse effects*
-
Mercaptopurine / therapeutic use
-
Mesalamine / administration & dosage
-
Mesalamine / adverse effects*
-
Mesalamine / therapeutic use
-
Methyltransferases / deficiency
-
Methyltransferases / genetics
-
Monosomy
-
Myelodysplastic Syndromes / etiology*
-
Myelodysplastic Syndromes / genetics
-
Myelodysplastic Syndromes / immunology
-
Myelodysplastic Syndromes / surgery
-
Prednisone / adverse effects*
-
Prednisone / therapeutic use
-
Young Adult
Substances
-
Immunosuppressive Agents
-
Cytarabine
-
Mesalamine
-
Budesonide
-
Etoposide
-
Mercaptopurine
-
Methyltransferases
-
thiopurine methyltransferase
-
Prednisone
-
Idarubicin